Antitumor Activity of the Selective MDM2 Antagonist Nutlin-3 Against Chemoresistant Neuroblastoma With Wild-Type p53

著录项

• 来源
  《Journal of the National Cancer Institute》 |2009年第22期|p.1562-1574|共13页
• 作者

  Tom Van Maerken Liesbeth Ferdinande Jasmien Taildeman Irina Lambertz Nurten Yigit Liesbeth Vercruysse Ali Rihani Martin Michaelis Jindrich Cinatl Jr Claude A. Cuvelier Jean-Christophe Marine Anne De Paepe Marc Bracke Frank Speleman and Jo Vandesompele;

  展开▼
• 作者单位

  Affiliations of authors: Center for Medical Genetics (TVM, NY, LV, AR, ADP, FS, JV), Department of Clinical Chemistry, Microbiology and Immunology (TVM), Department of Pathology (LF, JT, CAC), and Laboratory of Experimental Cancerology (MB), Ghent University Hospital, Ghent, Belgium;

  Laboratory for Molecular Cancer Biology, Flanders Interuniversity Institute for Biotechnology–Ghent University (VIB-UGent), Ghent, Belgium (IL, J-CM);

  Zentrum der Hygiene, Institut für Medizinische Virologie, Klinikum der J.W. Goethe Universität, Frankfurt am Main, Germany (MM, JC);

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类
• 关键词